Look Externally Not Internally for Innovation

Insight by

Sophie Kornowski, Ph.D., Partner at Gurnet Point Capital, and Doug Giordano, Managing Director, Perceptive Advisors speak with Yaron Werber, M.D., Biotechnology Analyst.  They discuss how they thought through valuations when they headed transactions at Roche and Pfizer, the importance of taking risks, and staying humble. They also speak about the importance of building relationships, getting internal alignment and support for deals, and offer a behind-the-scenes look at how deals are done.

Press play to listen to the podcast.

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.

More Like This

Themes 2022

Health Care Innovation

Read More
Ahead of the Curve®

Trials and Triumphs of Gene Editing: A Compendium

Read More

Getting to “Win-Win” in Partnerships

Read More